PDCD1 and neoplasm: Regulate tryptophan metabolism and SCFAs to enhance CD8+ T cell function, increase the production of IFN-γ and TNFα, reduce the inhibitory effect of Treg in the circulatory system, remodel the intestinal microbiota, and cooperate with PD-1 monoclonal antibody to exert anti-tumor effects.